The Bar Always Rises - 8/4/2026

Using the history of the mile record as an analogy, this piece argues that drug development's stubborn 10–15% success rate isn't stagnation — it is a rising bar. Even with the advent of AI, industry will once again find itself settling there due to the rising bar: then what?

https://www.linkedin.com/posts/brian-smith-67891a5_drugdevelopment-biostatistics-clinicalpharmacology-ugcPost-7490550176646877185-5wVK/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAEGlDwBwD0msjnYupwRjlV-PWIsMwwWd3w

‍ ‍